Search Results - "Tornin, Juan"
-
1
Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell cultures
Published in Nature protocols (01-06-2021)“…Cold atmospheric plasma (CAP) is a potential anticancer therapy. CAP has cytotoxic effects when applied either directly to cancer cell cultures or indirectly…”
Get full text
Journal Article -
2
Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma
Published in Scientific reports (23-07-2019)“…Osteosarcoma (OS) is the most common primary bone tumor but current therapies still have poor prognosis. Cold Atmospheric Plasma (CAP) and Plasma activated…”
Get full text
Journal Article Publication -
3
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies
Published in Stem cells international (01-01-2016)“…Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone. Although standard chemotherapy has significantly improved long-term…”
Get full text
Journal Article -
4
FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway
Published in Neoplasia (New York, N.Y.) (01-01-2018)“…Deregulated SRC/FAK signaling leads to enhanced migration and invasion in many types of tumors. In myxoid and round cell liposarcoma (MRCLS), an adipocytic…”
Get full text
Journal Article Publication -
5
Expression of FUS‐CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation
Published in Stem cells (Dayton, Ohio) (01-10-2013)“…Increasing evidence supports that mesenchymal stromal/stem cells (MSCs) may represent the target cell for sarcoma development. Although different sarcomas have…”
Get full text
Journal Article -
6
Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models
Published in Neoplasia (New York, N.Y.) (01-06-2017)“…Abstract Trabectedin has been approved for second-line treatment of soft tissue sarcomas. However, its efficacy to target sarcoma initiating cells has not been…”
Get full text
Journal Article -
7
Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
Published in Oncotarget (24-05-2016)“…Tumor initiating cells (TICs), responsible for tumor initiation, and cancer stem cells (CSCs), responsible for tumor expansion and propagation, are often…”
Get full text
Journal Article -
8
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
Published in EBioMedicine (01-04-2024)“…Sarcomas represent an extensive group of malignant diseases affecting mesodermal tissues. Among sarcomas, the clinical management of chondrosarcomas remains a…”
Get full text
Journal Article -
9
Bone Environment is Essential for Osteosarcoma Development from Transformed Mesenchymal Stem Cells
Published in Stem cells (Dayton, Ohio) (01-05-2014)Get full text
Journal Article -
10
The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042
Published in Journal of clinical medicine (02-08-2019)“…The frequent dysregulation of SRC family kinases (SFK) in multiple cancers prompted various inhibitors to be actively tested in preclinical and clinical…”
Get full text
Journal Article -
11
The multikinase inhibitor EC‐70124 synergistically increased the antitumor activity of doxorubicin in sarcomas
Published in International journal of cancer (01-07-2019)“…Cytotoxic drugs like doxorubicin remain as the most utilized agents in sarcoma treatment. However, advanced sarcomas are often resistant, thus stressing the…”
Get full text
Journal Article Publication -
12
Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer
Published in Free radical biology & medicine (20-08-2022)“…High-dose systemic chemotherapy constitutes a main strategy in the management of bone metastases, employing drugs like doxorubicin (DOX), related with severe…”
Get full text
Journal Article -
13
Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties
Published in Free radical biology & medicine (20-02-2021)“…The use of oxidative stress generated by Cold Atmospheric Plasma (CAP) in oncology is being recently studied as a novel potential anti-cancer therapy. However,…”
Get full text
Journal Article -
14
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Published in Biomedicines (14-01-2023)“…Drug resistance is a major problem in cancer treatment, as it limits the effectiveness of pharmacological agents and can lead to disease progression. Cold…”
Get full text
Journal Article -
15
Cold Plasma-Treated Ringer's Saline: A Weapon to Target Osteosarcoma
Published in Cancers (17-01-2020)“…Osteosarcoma (OS) is the main primary bone cancer, presenting poor prognosis and difficult treatment. An innovative therapy may be found in cold plasmas, which…”
Get full text
Journal Article Publication -
16
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells
Published in Free radical biology & medicine (20-11-2023)“…Osteosarcoma (OS) is an aggressive bone cancer with poor prognosis, largely due to the limited effectiveness of current treatments such as doxorubicin (DX)…”
Get full text
Journal Article -
17
Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma Therapy
Published in Journal of clinical medicine (23-02-2021)“…Osteosarcoma is the most common primary bone tumor, and its first line of treatment presents a high failure rate. The 5-year survival for children and…”
Get full text
Journal Article -
18
Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models
Published in International journal of molecular sciences (08-06-2022)“…Bone sarcomas have not shown a significant improvement in survival for decades, due, in part, to the development of resistance to current systemic treatments,…”
Get full text
Journal Article -
19
Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma
Published in Redox biology (01-06-2023)“…Osteosarcoma (OS) is a malignant type of bone cancer that arises in periods of increased bone formation. Curative strategies for these types of tumors have…”
Get full text
Journal Article -
20
Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling
Published in Biomedicine & pharmacotherapy (01-06-2023)“…Osteosarcomas are frequently associated to a poor prognosis and a modest response to current treatments. EC-8042 is a well-tolerated mithramycin analog that…”
Get full text
Journal Article